Opinion|Videos|January 27, 2025
Multidisciplinary Approaches to Atopic Dermatitis Management and Referrals
Panelists discuss the diagnosis and referral process for patients with pediatric atopic dermatitis (AD) from both the dermatologist and allergy perspectives, including when a child should be referred to a dermatologist and the importance of a multidisciplinary approach to care for optimizing AD management, with insights on the roles each team member plays in patient care.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Describe the patient journey for pediatric patients with AD and their Let’s talk about your perspective on diagnosis and referral of patients with atopic dermatitis from both the dermatologist and allergy perspective. When should a child see a dermatologist for atopic dermatitis?
- Discuss the referral process.
- How can a multidisciplinary approach to care help optimize the management of atopic dermatitis?
- What role does each member of the multidisciplinary team play in management of AD?
Advertisement
Related to this article
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
In 5.2 million US infants, newborn vitamin K nonreceipt rose to 6.8% by 2025 and was tied to a 47% higher bleeding risk by 6 months.
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
Jessica Nash, MD, IBCLC, shares strategies for assessing breastfeeding, identifying latch problems, and connecting families with lactation resources.
Find out the 4 FDA decisions to watch in November 2026 for pediatric care.
Michael Pistiner, MD, discusses how pediatricians can support food allergy management in schools through accurate diagnosis, emergency plans, and education.
Cenobamate sNDAs target PGTC seizures in patients ≥12 years and pediatric focal seizures; phase 3 PGTC data showed a 71.9% median reduction.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Skipping newborn vitamin K tied to 47% higher infant bleeding risk
2
Breastfeeding essentials: Assessing latch and milk transfer
3
Maternal RSVpreF 78% effective against infant RSV hospitalization
4
Study identifies gaps in infant RSV immunization timing
5